Product Images Rapaflo
View Photos of Packaging, Labels & Appearance
- structural formula - rapaflo 01
- Figure 1 Mean (±SD) Silodosin Steady State Plasma Concentration-Time Profile in Healthy Target-Aged Subjects Following Silodosin 8 mg Once Daily with Food - rapaflo 02
- Figure 2 Mean Change from Baseline in IPSS Total Score by Treatment Group and Visit in Study 1 - rapaflo 03
- Figure 3 Mean Change from Baseline in IPSS Total Score by Treatment Group and Visit in Study 2 - rapaflo 04
- Figure 4 Mean Change from Baseline in Qmax (mL/sec) by Treatment Group and Visit in Study 1 - rapaflo 05
- Figure 5 Mean Change from Baseline in Qmax (mL/sec) by Treatment Group and Visit in Study 2 - rapaflo 06
- Principal Display PanelNDC 0023-6142-30RAPAFLO8 mg per capsule30 CapsulesRx Only - rapaflo 07
- NDC 0023-6147-30RAPAFLO4 mg per capsule30 CapsulesRx Only - rapaflo 08
Product Label Images
The following 8 images provide visual information about the product associated with Rapaflo NDC 0023-6142 by Allergan, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structural formula - rapaflo 01
Figure 1 Mean (±SD) Silodosin Steady State Plasma Concentration-Time Profile in Healthy Target-Aged Subjects Following Silodosin 8 mg Once Daily with Food - rapaflo 02
Figure 2 Mean Change from Baseline in IPSS Total Score by Treatment Group and Visit in Study 1 - rapaflo 03
Figure 3 Mean Change from Baseline in IPSS Total Score by Treatment Group and Visit in Study 2 - rapaflo 04
The text appears to be a statistical result showing a change in the IPSS Total Score. The p-value is less than 0.0001, which suggests that the change is statistically significant. The rest of the text is not readable due to errors.*
Figure 4 Mean Change from Baseline in Qmax (mL/sec) by Treatment Group and Visit in Study 1 - rapaflo 05
Figure 5 Mean Change from Baseline in Qmax (mL/sec) by Treatment Group and Visit in Study 2 - rapaflo 06
Principal Display PanelNDC 0023-6142-30RAPAFLO8 mg per capsule30 CapsulesRx Only - rapaflo 07
NDC 0023-6147-30RAPAFLO4 mg per capsule30 CapsulesRx Only - rapaflo 08
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
